News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Next-generation imaging for evaluation in patients with prostate cancer after biochemical recurrence
Xavier Maldonado
Jan 23, 2025, 15:31

Next-generation imaging for evaluation in patients with prostate cancer after biochemical recurrence

Puigvert Foundation Barcelona shared an article by Xavier Maldonado, et al on X:

“Today in PiS Controversies in the use of next-generation imaging for evaluation and treatment decision-making in patients with prostate cancer after biochemical recurrence: views from a Spanish expert panel.“

Controversies in the use of next-generation imaging for evaluation and treatment decision-making in patients with prostate cancer after biochemical recurrence: views from a Spanish expert panel.

Authors: Xavier Maldonado, et al.

Next-generation imaging for evaluation in patients with prostate cancer after biochemical recurrence

Biochemical Recurrence cancer fight against cancer Fundació Puigvert Barcelona Global fight against cancer OncoDaily Oncology PIs prostate cancer Xavier Maldonado
Special Coverage
Blog
Apr 14, 2025, 04:50
Joshua Reuss: Excellent updates on thymoma/thymic carcinoma from Chul Kim at TexasLung25
Blog
Apr 14, 2025, 04:39
Michael Duruisseaux: Phase 3 DeLLphi-304 - Tarlatamab Meets OS Endpoint in SCLC
Blog
Apr 14, 2025, 03:45
Alfredo Addeo: The Phase 3 DeLLphi-304 trial met its primary endpoint
Blog
Apr 14, 2025, 01:50
Giannis Mountzios: Tarlatamab Improves Overall Survival in Advanced SCLC
Blog
Apr 14, 2025, 01:36
Sumanta K. Pal: Best Talk This Year - City of Hope GU Retreat
Blog
Apr 14, 2025, 01:08
The Faces of Cancer Care: Strengthening the Workforce, Saving Lives - UICC
Blog
Apr 13, 2025, 19:03
Tigran Byuzandyan: Delegation from the National Oncology Center of Armenia Explores Collaboration with Heidelberg University Hospital
Blog
Apr 13, 2025, 18:24
Akhil Santhosh: First-Line Adagrasib and Pembrolizumab for Metastatic NSCLC
Blog
Apr 13, 2025, 18:15
12th Annual Cholangiocarcinoma Foundation Conference Comes to a Close
Blog
Apr 13, 2025, 17:50
Noemi Reguart: First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy in SCLC
Blog
Apr 13, 2025, 17:15
Applications are open for the M2ICOS project - European School of Oncology
Stories
Apr 13, 2025, 17:11
From Resident to Survivor: Dr. Jessica Firdman Moore’s cancer journey at Sylvester Comprehensive Cancer Center